Roman Hrstka - Concepedia

Author

Roman Hrstka

Masaryk Memorial Cancer Institute ORCID

Also Known As

Hrstka R, Hrstka, Roman, R Hrstka, R. Hrstka, ROMAN HRSTKA, Roman Hrstka, Roman Hrstka (394468)

217

Publications

4.6K

Citations

H-Index

111

Concepts

All Affiliations

Masaryk Memorial Cancer Institute Masaryk University Charles University Czech Academy of Sciences, Institute of Chemical Process Fundamentals Czech Academy of Sciences

About

Roman Hrstka is an author at Masaryk Memorial Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	38	1.5K
2	Natural Sciences	11	12	639
3	Engineering	9	9	332
4	Biochemistry	3	3	75
5	Public Health	2	2	47

Roman Hrstka

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances Petr Müller, Eva Růčková, Petr Halada, Oncogene Protein FunctionSignal TransductionC-terminal PhosphorylationProtein FoldingNatural Sciences	2012	223
Chaperone-dependent stabilization and degradation of p53 mutants Petr Müller, Roman Hrstka, David Coomber, Oncogene Genome InstabilityNatural SciencesMolecular BiologyChaperonesTumor Suppressor	2008	179
Lipidomic profiling of human serum enables detection of pancreatic cancer Denise Wolrab, Robert Jirásko, Eva Cífková, Nature Communications	2022	162
MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients Ondřej Slabý, Radek Lakomý, Pavel Fadrus, Neoplasma PathologyMgmt Methylation StatusHigh-grade GliomasGliomaEpigenetics	2010	135
Discriminating functional and non‐functional p53 in human tumours by p53 and MDM2 immunohistochemistry Rudolf Nenutil, Jana Šmardová, Šárka Pavlová, The Journal of Pathology	2005	135
Biomarker Discovery in Low-Grade Breast Cancer Using Isobaric Stable Isotope Tags and Two-Dimensional Liquid Chromatography-Tandem Mass Spectrometry (iTRAQ-2DLC-MS/MS) Based Quantitative Proteomic Analysis Pavel Bouchal, Theodoros I. Roumeliotis, Roman Hrstka, Journal of Proteome Research	2008	113
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers Roman Hrstka, Rudolf Nenutil, Argyro Fourtouna, Oncogene Breast OncologyTamoxifen-treated Breast CancersMedicinePathologyCancer Biology	2010	112
Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry Pavel Bouchal, Olga T. Schubert, Jakub Faktor, Cell Reports Breast OncologyEngineeringPathologyTumor BiologyCancer Detection	2019	105
Control of anterior <scp>GR</scp> adient 2 ( <scp>AGR</scp> 2) dimerization links endoplasmic reticulum proteostasis to inflammation Marion Maurel, Joanna Obacz, Tony Avril, EMBO Molecular Medicine	2019	100
AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway Roman Hrstka, Pavla Bouchalová, Eva Michalová, Molecular Oncology	2015	68

Page 1